Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Neonatal Vancomycin Trial (NeoVanc)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02790996
Recruitment Status : Recruiting
First Posted : June 6, 2016
Last Update Posted : June 29, 2018
St George's, University of London
Institut National de la Santé Et de la Recherche Médicale, France
University of Tartu
Consorzio per Valutazioni Biologiche e Farmacologiche
University of Liverpool
Therakind limited
Bambino Gesù Hospital and Research Institute
Servicio Madrileño de Salud, Madrid, Spain
Aristotle University Of Thessaloniki
University of Edinburgh
SYNAPSE Research Management Partners S.L
European Commission
Information provided by (Responsible Party):
PENTA Foundation

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 1, 2018
Estimated Study Completion Date : February 1, 2019